GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends
Zhou, J.; Wild, C.
Current Topics in Medicinal Chemistry 19(16): 1363-1364
2019
ISSN/ISBN: 1568-0266 PMID: 31513505 Document Number: 699580
Document emailed within 1 workday
Related Documents
Frigeri, A.; Nicchia, G.Paola.; Svelto, M. 2007: Aquaporins as targets for drug discovery Current Pharmaceutical Design 13(23): 2421-2427Hofstadler, S.A.; Griffey, R.H. 2000: Mass spectrometry as a drug discovery platform against RNA targets Current Opinion in Drug Discovery and Development 3(4): 423-431
Levens, N. 2005: Are stimulators of fat oxidation interesting drug discovery targets? Current Opinion in Investigational Drugs 6(4): 363
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Brea, Jé.; Castro-Palomino, J.; Yeste, S.; Cubero, E.; Párraga, A.; Domínguez, E.; Loza, Mía.Isabel. 2010: Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors Current Topics in Medicinal Chemistry 10(5): 493-503
Bowen, J.Phillip.; Zhong, H.Andrew. 2015: Advances in Drug Discovery: Many Approaches, One Goal Current Topics in Medicinal Chemistry 2015
Prathipati, P.; Mizuguchi, K. 2016: Systems Biology Approaches to a Rational Drug Discovery Paradigm Current Topics in Medicinal Chemistry 16(9): 1009-1025
Gupta, A.K. 2018: Current Advances in Computational Approaches for Drug Discovery- Part II Current Topics in Medicinal Chemistry 18(27): 2267
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Tillement, J.P.; Albengres, E.; Riani, P.; Bree, F. 1985: Present and future trends in drug monitoring International Journal of Clinical Pharmacology Therapy and Toxicology 23(Suppl 1): S68-S73
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Tanaka, H. 2013: Search for synapses-forming mechanism for the discovery of therapeutic targets Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(3): 99
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Castro-Santos, P.; Laborde, C.M.; Díaz-Peña, R. 2015: Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers Clinical and Experimental Rheumatology 33(2): 279-286
Lou, L.; Velligan, M.; Roberts, C.; Stevens, D.A.; Clemons, K.V. 2002: DNA binding compounds targeting fungal pathogens: an emerging concept in the discovery of novel antifungal agents Current Opinion in Investigational Drugs 3(10): 1437-1445
Scheen, A.J. 1998: Drug clinics. how i treat various metabolic diseases treated by a drug intervention that targets the intestine Revue Medicale de Liege 53(11): 646-650
Belitser, V.A. 1977: Oxidative phosphorylation: discovery, early studies, new approaches Molekuliarnaia Biologiia 11(6): 1234-1237
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293